Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS

Journal of Assisted Reproduction and Genetics

Volumn 29, Issue 3, 2012, Pages 249-253

  Castillo, Juan C ^a   Juan, Garcia Velasco ^b   Humaidan, Peter ^c  

^a FIV Valencia   (Spain)

^b IVI Madrid   (Spain)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

GnRH agonist; GnRH antagonist; GnRHa Empty follicle syndrome; Hcg; Triggering

Indexed keywords

CHORIONIC GONADOTROPIN; GANIRELIX; GONADORELIN AGONIST; MICROGYNON30; RECOMBINANT FOLLITROPIN; TRIPTORELIN; UNCLASSIFIED DRUG; DRUG DERIVATIVE; GONADORELIN; HORMONE ANTAGONIST; RECOMBINANT PROTEIN;

ARTICLE; DONOR; EMPTY FOLLICLE SYNDROME; FERTILIZATION IN VITRO; INCIDENCE; OOCYTE MATURATION; OVARY DISEASE; OVARY FOLLICLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ADULT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; INFERTILITY; OOCYTE DONATION; OVULATION INDUCTION; PATHOPHYSIOLOGY;

ADULT; CHORIONIC GONADOTROPIN; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INCIDENCE; INFERTILITY; OOCYTE DONATION; OVARIAN DISEASES; OVARIAN FOLLICLE; OVULATION INDUCTION; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TISSUE DONORS; YOUNG ADULT;

EID: 84863213788     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-011-9704-8     Document Type: Article

References (29)

1. Humaidan P, Kol S, Papanikolaou E, The Copenhagen GnRH Agonist Triggering Workshop Group. GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update. 2011;17:510-4.
2. Honnma H, Hashiba Y, Asada Y, Endo T. Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: two case reports. Eur J Obstet Gynecol Reprod Biol In Press. doi:10.1016/j.ejogrb.2011.03.002.
3. Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a freeze-all strategy: a prospective multicentric study. Fertil Steril. 2011;95:2029-33.
4. Ben-Shlomo I, Schiff E, Levran D, Ben-Rafael Z. Failure of oocyte retrieval during invitro fertilization: a sporadic event rather than a syndrome. Fertil Steril. 1991;55:324-7.
5. Awonuga A, Govindbhai J, Zierke S, Schnauffer K. Continuing the debate on empty follicle syndrome: can it be associated with normal bioavailability of b-human chorionic gonadotrophin on the day of oocyte recovery? Hum Reprod. 1998;13:1281-4. (Pubitemid 28279183)
6. Zreik TG, Garcia-Velasco JA, Vergara TM, Arici A, Olive D, Jones EE. Empty follicle syndrome: evidence for recurrence. Hum Reprod. 2000;15:999-1002. (Pubitemid 30251289)
7. Zegers-Hochschild F, Fernandez E, Machenna A, Fabres C, Alteiri E, Lopez T. The empty follicle syndrome: a pharmaceutical industry syndrome. Hum Reprod. 1995;10:2262-5.
8. Ndukwe G, Thornton S, Fishel S, Dowell K, Aloum M, Green S. 'Curing' empty follicle syndrome. Hum Reprod. 1997;12:21-3.
9. Ubaldi F, Nagy Z, Janssenwillen C, Smitz J, Van Steirteghem A, Devroey P. Ovulation by repeated human chorionic gonadotrophin in 'empty follicle syndrome' yields a twin clinical pregnancy. Hum Reprod. 1997;12:454-6. (Pubitemid 27156435)
10. Quintans CJ, Donaldson MJ, Blanco LA, Pasqualini RS. Empty follicle syndrome due to human errors: its occurrence in an in-vitro fertilization programme. Hum Reprod. 1998;13:2703-5. (Pubitemid 28482713)
11. Gonen Y, Balakier H, Powell W, Casper RF. Use of gonadotropinreleasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab. 1990;71:918-22.
12. Itskovitz J, Boldes R, Levron J, Erlik Y, Kahana L, Brandes JM. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropinreleasing hormone agonist. Fertil Steril. 1991;56:213-20.
13. Hoff JD, Quigley ME, Yen SS. Hormonal dynamics at midcycle: a reevaluation. J Clin Endocrinol Metab. 1983;57:792-6. (Pubitemid 13013538)
14. Damewood MD, Shen W, Zacur HA, Schlaff WD, Rock JA, Wallach EE. Disappearance of exogenously administered human chorionic gonadotropin. Fertil Steril. 1989;52:398-400. (Pubitemid 19228282)
15. Weissman A, Lurie S, Zalel Y, Goldchmit R, Shoham Z. Human chorionic gonadotropin: pharmacokinetics of subcutaneous administration. Gynecol Endocrinol. 1996;10:273-6. (Pubitemid 26343488)
16. Stevenson TL, Lashen H. Empty follicle syndrome: the reality of a controversial syndrome, a systematic review. Fertil Steril. 2008;90:691-8.
17. Parneix I, Emperaire JC, Ruffie A, Parneix P. Comparison of different protocols of ovulation induction, by GnRH agonists and chorionic gonadotropin. Gynecol Obstet Fertil. 2001;29:100-5. (Pubitemid 32182899)
18. Díaz I, Guillén A, Pacheco A, Requena A, Garcia-Velasco JA. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination. J Reprod Med. 2008;53:33-9. (Pubitemid 351219777)
19. Fauser BC, de Jong D, Olivennes F, Wramsby H, Tay C, Itskovitz-Eldor J, van Hooren HG. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab. 2002;87:709-15. (Pubitemid 34158241)
20. Engmann L, Siano L, Schmidt D, Nulsen J, Maier D, Benadiva C. GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS. Reprod Biomed Online. 2006;13:639-44. (Pubitemid 44760886)
21. Bodri D, Guillén JJ, Trullenque M, Schwenn K, Esteve C, Coll O. Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study. Fertil Steril. 2010;93:2418-20.
22. Yariz KO,Walsh T, Uzak A, Spiliopoulos M, Duman D, Onalan G, King MC, Tekin M. Inherited mutation of the luteinizing hormone/ choriogonadotropin receptor (LHCGR) in empty follicle syndrome. Fertil Steril. 2011 (in press).
23. Khalaf Y, Braude P. 'Curing' empty follicle syndrome. Hum Reprod. 1997;12:1601.
24. Tsuiki A, Rose BI, Hung TT. Steroid profiles of follicular fluids from a patient with the empty follicle syndrome. Fertil Steril. 1988;49:104-7. (Pubitemid 18033900)
25. Beranova M, Oliveira LM, Bédécarrats GY, Schipani E, Vallejo M, Ammini AC, Quintos JB, Hall JE, Martin KA, Hayes FJ, Pitteloud N, Kaiser UB, Crowley Jr WF, Seminara SB. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2001;86:1580-8. (Pubitemid 32374907)
26. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab. 2000;85:3365-9.
27. Piersma D, Verhoef-Post M, Berns EM, Themmen AP. LH receptor gene mutations and polymorphisms: an overview. Mol Cell Endocrinol. 2007;260-262:282-6. (Pubitemid 44792342)
28. Alviggi C, Clarizia R, Pettersson K, Mollo A, Humaidan P, Strina I, Coppola M, Ranieri A, D'Uva M, De Placido G. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online. 2009;18:9-14.
29. Pettersson KS, Söderholm JR. Individual differences in lutropin immunoreactivity revealed by monoclonal antibodies. Clin Chem. 1991;37:333-40. (Pubitemid 21892651)